C5AR1 and endometrial carcinoma: In addition to confirming published findings, we found noticeable C5aR1 expression in many tumour entities, such as in thyroid carcinomas, small-cell lung cancer, gastrointestinal stromal tumours and endometrial carcinomas, for the first time.